Project description
A highly accurate diagnostic tool for detecting the earliest stages of cancer
Cancer patient survival is strongly associated with the stage of disease progression at the time of diagnosis. Romanian start-up company Artificial Intelligence Expert (AIE) develops solutions to facilitate the early diagnosis and screening for various types of cancers. AIE focuses on the transition to liquid biopsies, microarray, and next-generation sequencing (NGS) for molecular diagnostics. The technology detects cancer at the earliest stages using circulating microRNAs instead of the currently used circulating tumor DNA or cancer cells. The earliest detection of cancer progression is highly accurate and employs artificial intelligence to analyse microRNA profiles from microarray and NGS data. The EU-funded AI-MICADIS project enables the company to identify partnerships and optimise the best business strategy to bring the technology to the market.
Fields of science
- social sciencessociologydemographymortality
- natural sciencesbiological sciencesgeneticsDNA
- medical and health sciencesclinical medicineoncology
- natural sciencescomputer and information sciencesartificial intelligencemachine learningdeep learning
- natural sciencescomputer and information sciencesdata sciencedata processing
Programme(s)
Funding Scheme
SME-1 - SME instrument phase 1Coordinator
400310 Cluj Napoca
Romania
See on map